Patents by Inventor Anders Bergh

Anders Bergh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • LARGE SCALE PROCESS OF 3,3'-DIDEOXY-3,3'-BIS-[4-(3-FLUOROPHENYL)-1H-1,2,3-TRIAZOL-1-YL]-1,1'-SULFANEDIYL-DI-BETA-D-GALACTOPYRANOSIDE
    Publication number: 20220251132
    Abstract: The present invention relates to a process for preparing a compound of formula (I) wherein said process is suitable for large scale synthesis.
    Type: Application
    Filed: June 24, 2020
    Publication date: August 11, 2022
    Applicant: GALECTO BIOTECH AB
    Inventors: Fredrik ZETTERBERG, Andrew TYRELL, Ulf NILSSON, Anders BERGH, Jonathan CUMMINS, Alexander WEYMOUTH-WILSON, Robert CLARKSON
  • METHODS FOR DIAGNOSIS AND PROGNOSIS OF PROSTATE CANCER
    Publication number: 20220213552
    Abstract: The invention relates to a method for determining tumor aggressiveness in a subject diagnosed with prostate cancer and having a tumor, said method comprising (a) evaluating the level of cell differentiation in a sample comprising tumor-derived material from the said subject; and (b) evaluating the level of proliferating cells in the said sample. In a further aspect, the invention comprises determining the ratio between the level of proliferating cells and the level of cell differentiation and in the sample. The invention further relates to methods for determining the need of curative treatment in a subject diagnosed with prostate cancer, as well as to methods for treating prostate cancer in a subject in need thereof.
    Type: Application
    Filed: February 21, 2020
    Publication date: July 7, 2022
    Inventors: Pernilla Wikström, Anders Bergh, Elin Thysell
  • METHODS FOR DIAGNOSIS AND PROGNOSIS OF PROSTATE CANCER
    Publication number: 20220170105
    Abstract: The invention relates to methods for determining tumor aggressiveness and molecular subtype of metastases that are present, or that may eventually develop, in a subject diagnosed with prostate cancer. The methods of the invention comprise determining the molecular subtype of a sample by evaluating levels of subtype-associated gene transcripts. The invention further relates to methods for determining the metastatic potential in a subject diagnosed with prostate cancer and having a primary tumor, as well as to methods for determining the treatment for a subject diagnosed with prostate cancer metastasis.
    Type: Application
    Filed: February 21, 2020
    Publication date: June 2, 2022
    Applicant: Phenotype Diagnostics AB
    Inventors: Pernilla Wikström, Anders Bergh, Elin Thysell
  • PROCESS FOR PREPARING HYDROXYLAMINES AND MEDICAMENTS
    Publication number: 20140206761
    Abstract: There is provided a process for the preparation of a compound of formula II, wherein R1, R2, R3 and R4 are as described in the description. Such compounds may, for example, be useful intermediates in the synthesis of drugs such as Dronedarone.
    Type: Application
    Filed: March 24, 2014
    Publication date: July 24, 2014
    Applicant: Cambrex Karlskoga AB
    Inventors: Lars O. HANSSON, Anders BERGH, Lars EKLUND
  • NEW PROCESS FOR PREPARING HYDROXYLAMINES AND MEDICAMENTS
    Publication number: 20120122971
    Abstract: There is provided a process for the preparation of a compound of formula II, wherein R1, R2, R3 and R4 are as described in the description. Such compounds may, for example, be useful intermediates in the synthesis of drugs such as Dronedarone.
    Type: Application
    Filed: April 6, 2010
    Publication date: May 17, 2012
    Applicant: CAMBREX KARLSKOGA AB
    Inventors: Lars O. Hansson, Anders Bergh, Lars Eklund
  • PROCESS FOR PREPARING ENANTIOMERICALLY ENRICHED ALKALOIDS
    Publication number: 20120041022
    Abstract: There is provided a process for the preparation of a single enantiomer of anhydroecgonine (of formula I): or a salt thereof, in which R1 is as defined in the description. Such single enantiomers may, for example, be useful intermediates in the synthesis of pharmaceuticals, in which the enantioselectivity is important.
    Type: Application
    Filed: January 29, 2010
    Publication date: February 16, 2012
    Applicant: CAMBREX KARLSKOGA
    Inventors: Lars O. Hansson, Anders Bergh